Current NDC auxiliary source row compounder:415

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69374-987
Product Ndc: 69374-987
Product Ndc Digits: 69374987
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Ropivacaine Hydrochloride 200 mg/100 mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ropivacaine Hydrochloride 200 mg/100 mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INFILTRATION
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Nephron Sterile Compounding Center, LLC
Establishment Name: Nephron Sterile Compounding Center, LLC
Establishment Fei: [empty]
Substance Name: ROPIVACAINE HYDROCHLORIDE
Active Ingredients Info: 2 mg/1 mL
History Active Ingredients Raw: ROPIVACAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 2 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 69374-987-50
Package Ndc: 69374-987-50
Package Ndc Digits: 6937498750
Package Ndc11: 69374098750
Package Description: 10 BAG in 1 CASE (69374-987-50) > 500 mL in 1 BAG
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:415
Source Row Number: 415
Source Row Hash: a8120fdf7200529ca555b486a44dee955152743f18b173497ba146464b201364
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INFILTRATION",
    "PRODUCTNDC": "69374-987",
    "DEASCHEDULE": "",
    "LABELERNAME": "Nephron Sterile Compounding Center, LLC",
    "SUBSTANCENAME": "ROPIVACAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "69374-987-50",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ropivacaine Hydrochloride 200 mg/100 mL",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Ropivacaine Hydrochloride 200 mg/100 mL",
    "PACKAGEDESCRIPTION": "10 BAG in 1 CASE (69374-987-50)  > 500 mL in 1 BAG",
    "ACTIVEINGREDIENTSINFO": "2 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:415
Source Row Number: 415
Status Scope: package
Lookup Ndc: 69374-987-50
Lookup Ndc Digits: 6937498750
Product Ndc: 69374-987
Product Ndc Digits: 69374987
Package Ndc: 69374-987-50
Package Ndc Digits: 6937498750
Package Ndc11: 69374098750
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: a8120fdf7200529ca555b486a44dee955152743f18b173497ba146464b201364
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20